Silencing MALAT1 represses pathological progression, inflammation, and vascular smooth muscle cell phenotype switching by regulating the SEMA3C-mediated Smad pathway in intracranial aneurysms. The gene discussed is MALAT1; the disease is Dilatation of the cerebral artery.